Q1 2026 Earnings Summary
Metric | YoY Change | Reason |
---|---|---|
Total Revenue | -2.7% ( ) | Q1 2026 total revenue fell to $692.8 million from $711.0 million in Q1 2025, a modest decline that suggests mild market contraction and perhaps lower demand in certain segments continuing trends seen in the prior period ( ). |
Operating Income | Turned positive from a loss of $1,758.0 million to $32.6 million ( ) | Q1 2026 saw a dramatic turnaround in operating income, reversing a steep operating loss in Q1 2025 by reducing the burden of one‑time and non‑cash charges, which indicates improved operational efficiency and stabilization compared to the previous period ( ). |
Net Loss | Narrowed significantly from $1,706.0 million to $12.7 million ( ) | The net loss contracted sharply in Q1 2026 as improved operating performance and tighter cost management largely offset previous heavy charges, suggesting a strong recovery trajectory relative to Q1 2025 ( ). |
Research analysts covering QuidelOrtho.